Thomas will present the findings at the following oral presentation session: Oral Presentations - Weighing Opportunities of Incretin-Based Therapy in Obesity Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity Presented on Sunday, June 23, 2024 at 2:45 PM EDT ### About the ADAs Scientific Sessions The ADA's 84th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Orlando, FL on June 21-24
Epithalon has been studied specifically for its ability to protect photoreceptor cells in the retina
Weight loss injections offer a modern solution to breaking through that plateau
Semaglutide stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner, meaning the insulin response scales with how high blood glucose actually is
The hearing provides the court with an early view of the scientific issues that will probably influence future pretrial decisions in the litigation